Jane Street Group, LLC Rapt Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022
SELL
$17.02 - $40.22 $418,692 - $989,412
-24,600 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$29.5 - $39.5 $283,200 - $379,200
9,600 Added 64.0%
24,600 $904,000
Q3 2021

Nov 16, 2021
SELL
$29.86 - $39.47 $1.37 Million - $1.81 Million
-45,800 Reduced 75.33%
15,000 $466,000
Q2 2021

Aug 16, 2021
BUY
$17.99 - $40.02 $537,901 - $1.2 Million
29,900 Added 96.76%
60,800 $1.93 Million
Q1 2021

May 18, 2021
BUY
$16.0 - $24.46 $494,400 - $755,814
30,900 New
30,900 $686,000

Others Institutions Holding RAPT

# of Institutions
104
Shares Held
27.1M
Call Options Held
26.7K
Put Options Held
2.4K
View Full List

About RAPT Therapeutics, Inc.

RAPT Quotes by TradingView
  • Ticker RAPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,656,600
  • Market Cap $38M
  • Description
  • RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...
More about RAPT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email